Australia markets open in 9 hours 50 minutes

Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8800+0.0100 (+0.35%)
As of 10:10AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate-0.42-0.43-1.63-1.77
Low estimate-0.48-0.52-2.06-2.49
High estimate-0.38-0.36-1.26-1.23
Year ago EPS-0.45-0.32-1.37-1.63
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate11.67M11.67M52.93M36.67M
Low estimate7.5M7.5M30M10M
High estimate15M15M68.8M70M
Year ago sales10.34M20.01M64.7M52.93M
Sales growth (year/est)12.80%-41.70%-18.20%-30.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.45-0.53-0.29-0.39
Actual EPS-0.45-0.32-0.35-0.27
Difference00.21-0.060.12
Surprise %0.00%39.60%-20.70%30.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.42-0.43-1.63-1.77
7 days ago-0.42-0.43-1.67-1.8
30 days ago-0.42-0.43-1.67-1.8
60 days ago-0.38-0.38-1.57-1.48
90 days ago-0.38-0.38-1.57-1.48
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A11
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesPSTXIndustrySector(s)S&P 500
Current qtr.6.70%N/AN/AN/A
Next qtr.-34.40%N/AN/AN/A
Current year-19.00%N/AN/AN/A
Next year-8.60%N/AN/AN/A
Next 5 years (per annum)2.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A